These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8595281)

  • 1. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study.
    Lehtinen M; Dillner J; Knekt P; Luostarinen T; Aromaa A; Kirnbauer R; Koskela P; Paavonen J; Peto R; Schiller JT; Hakama M
    BMJ; 1996 Mar; 312(7030):537-9. PubMed ID: 8595281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer.
    Dillner J; Lehtinen M; Björge T; Luostarinen T; Youngman L; Jellum E; Koskela P; Gislefoss RE; Hallmans G; Paavonen J; Sapp M; Schiller JT; Hakulinen T; Thoresen S; Hakama M
    J Natl Cancer Inst; 1997 Sep; 89(17):1293-9. PubMed ID: 9293920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
    Ylitalo N; Josefsson A; Melbye M; Sörensen P; Frisch M; Andersen PK; Sparén P; Gustafsson M; Magnusson P; Pontén J; Gyllensten U; Adami HO
    Cancer Res; 2000 Nov; 60(21):6027-32. PubMed ID: 11085523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries).
    Hakama M; Luostarinen T; Hallmans G; Jellum E; Koskela P; Lehtinen M; Thoresen S; Youngman L; Hakulinen T
    Cancer Causes Control; 2000 Oct; 11(9):783-90. PubMed ID: 11075866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers.
    Bjørge T; Dillner J; Anttila T; Engeland A; Hakulinen T; Jellum E; Lehtinen M; Luostarinen T; Paavonen J; Pukkala E; Sapp M; Schiller J; Youngman L; Thoresen S
    BMJ; 1997 Sep; 315(7109):646-9. PubMed ID: 9310566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries.
    Lehtinen M; Koskela P; Jellum E; Bloigu A; Anttila T; Hallmans G; Luukkaala T; Thoresen S; Youngman L; Dillner J; Hakama M
    Am J Epidemiol; 2002 Oct; 156(8):687-92. PubMed ID: 12370156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and determinants of human papillomavirus genital infection in men.
    Franceschi S; Castellsagué X; Dal Maso L; Smith JS; Plummer M; Ngelangel C; Chichareon S; Eluf-Neto J; Shah KV; Snijders PJ; Meijer CJ; Bosch FX; Muñoz N
    Br J Cancer; 2002 Mar; 86(5):705-11. PubMed ID: 11875730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.
    Anttila T; Saikku P; Koskela P; Bloigu A; Dillner J; Ikäheimo I; Jellum E; Lehtinen M; Lenner P; Hakulinen T; Närvänen A; Pukkala E; Thoresen S; Youngman L; Paavonen J
    JAMA; 2001 Jan; 285(1):47-51. PubMed ID: 11150108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines.
    Smith JS; Muñoz N; Herrero R; Eluf-Neto J; Ngelangel C; Franceschi S; Bosch FX; Walboomers JM; Peeling RW
    J Infect Dis; 2002 Feb; 185(3):324-31. PubMed ID: 11807714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.
    Arnheim Dahlström L; Andersson K; Luostarinen T; Thoresen S; Ögmundsdottír H; Tryggvadottír L; Wiklund F; Skare GB; Eklund C; Sjölin K; Jellum E; Koskela P; Wadell G; Lehtinen M; Dillner J
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2541-50. PubMed ID: 21994401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
    Koskela P; Anttila T; Bjørge T; Brunsvig A; Dillner J; Hakama M; Hakulinen T; Jellum E; Lehtinen M; Lenner P; Luostarinen T; Pukkala E; Saikku P; Thoresen S; Youngman L; Paavonen J
    Int J Cancer; 2000 Jan; 85(1):35-9. PubMed ID: 10585579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
    Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
    Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local studies address a previously hidden sexually transmitted disease: human papillomavirus and cervical neoplasia.
    Goodman MT
    Hawaii Med J; 2001 Sep; 60(9):236-8. PubMed ID: 11802562
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.
    Muñoz N; Franceschi S; Bosetti C; Moreno V; Herrero R; Smith JS; Shah KV; Meijer CJ; Bosch FX;
    Lancet; 2002 Mar; 359(9312):1093-101. PubMed ID: 11943256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.
    Koutsky LA; Holmes KK; Critchlow CW; Stevens CE; Paavonen J; Beckmann AM; DeRouen TA; Galloway DA; Vernon D; Kiviat NB
    N Engl J Med; 1992 Oct; 327(18):1272-8. PubMed ID: 1328880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer.
    Sundström K; Ploner A; Arnheim-Dahlström L; Eloranta S; Palmgren J; Adami HO; Ylitalo Helm N; Sparén P; Dillner J
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26160881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity in invasive cervical carcinoma associated with human papillomavirus types 16 and 18 infection.
    Park TK; Kim SN; Lee CH
    Int J Gynaecol Obstet; 1994 Jul; 46(1):67-8. PubMed ID: 7805989
    [No Abstract]   [Full Text] [Related]  

  • 20. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.
    Franceschi S; Rajkumar T; Vaccarella S; Gajalakshmi V; Sharmila A; Snijders PJ; Muñoz N; Meijer CJ; Herrero R
    Int J Cancer; 2003 Oct; 107(1):127-33. PubMed ID: 12925967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.